QUOTED. July 12, 2018. Peter Pronovost.
Medtronic's agreement to provide continuous glucose monitor and insulin pump systems to UnitedHealthcare members improved patient-outcomes in the first year, according to an analysis. See what Peter Pronovost, the insurance company's chief medical officer, said about it here.
"The first-year results are encouraging, and we will monitor patients using Medtronic pump therapies to ensure we continue to see improved quality of care, fewer hospitalizations, and lower costs." Peter Pronovost, chief medical officer, UnitedHealthcare
- Find out more:Medtronic and UnitedHealthcare Encouraged By First-Year Results From Value-Based Agreement
Click here for a free trial of Medtech Insight